Lv1
10 积分 2024-08-06 加入
Regulation of the c-Abl and Bcr–Abl tyrosine kinases
1天前
已完结
Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the G2 DNA Damage Checkpoint
1个月前
已完结
Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15
2个月前
已完结
Synthetic lethality and cancer
2个月前
已完结
Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
2个月前
已完结
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
2个月前
已完结
Interleukin‐1 receptor‐associated kinase (IRAK) ‐1‐ mediated NF‐κ activation requires cytosolic and nuclear activity
2个月前
已完结
504MO Phase I study of the PKMYT1 inhibitor lunresertib (lunre) in combination with FOLFIRI in advanced gastrointestinal (GI) cancers (MINOTAUR study)
3个月前
已完结
Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer
3个月前
已完结
PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling
3个月前
已完结
皖公网安备34019202002308
